Insider holders · CIK 0001208261
IMMUNE PHARMACEUTICALS INC · IMNP
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Daniel Gedeon TeperCEO | 5,865,280 | — | 5,865,280 | Oct 11, 2016 · 6:10 pm EDT | Form 4 |
| Daniel KazadoDirector | 1,145,171 | — | 1,145,171 | Jan 4, 2017 · 5:09 pm EST | Form 4 |
| Monica E. LuchiEVP & CMO | 777,778 | — | 777,778 | Aug 4, 2016 · 9:41 pm EDT | Form 4 |
| Anthony S. FiorinoChief Medical Officer and COO | 75,000 | — | 75,000 | May 23, 2018 · 1:16 pm EDT | Form 4 |
| Rene Pierre AzriaDirector | 50,000 | — | 50,000 | Sep 16, 2015 · 5:17 pm EDT | Form 4 |
| David SidranskyDirector | 21,699 | — | 21,699 | Jan 12, 2015 · 5:16 pm EST | Form 4 |
| Jeffrey PaleyDirector | 8,000 | — | 8,000 | Mar 1, 2016 · 6:05 pm EST | Form 3 |
| John MilitelloSee Remarks | 2,000 | — | 2,000 | Jan 5, 2016 · 5:01 pm EST | Form 3 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.